The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law'  and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate